Clinical Scorecard: The Relationship of Tear Film Instability and Higher-Order Aberrations to Refractive Variability

At a Glance

Key Highlights

• Tear film instability leads to fluctuating vision and inconsistent refractive measurements due to dynamic higher-order aberrations.
• Ocular surface inflammation drives tear film instability, creating a self-perpetuating cycle that degrades optical quality.
• Stabilizing the ocular surface before refraction improves measurement repeatability, prescription accuracy, and patient satisfaction.

Guideline-Based Recommendations

Diagnosis

• Assess tear film stability and ocular surface inflammation prior to refractive measurements.
• Use wavefront aberrometry to detect increased higher-order aberrations during interblink intervals.
• Recognize inconsistent autorefractor and subjective refraction results as potential indicators of tear film instability.

Management

• Treat underlying ocular surface inflammation to restore tear film stability rather than relying solely on tear supplementation.
• Prioritize ocular surface optimization before prescribing glasses, fitting contact lenses, or planning surgery.
• Repeat refractive measurements after ocular surface treatment to ensure accuracy.

Monitoring & Follow-up

• Monitor patient-reported visual fluctuations and dissatisfaction as signs of unstable tear film.
• Evaluate repeatability of objective and subjective refractive measurements over time.
• Assess corneal topography and keratometry quality to detect tear film-related distortions.

Risks

• Proceeding with refraction in the presence of untreated ocular surface disease risks inaccurate prescriptions and poor visual outcomes.
• Unstable optical interfaces increase likelihood of patient dissatisfaction, remakes, and increased clinical costs.
• Repeated prescription changes may erode patient confidence and perceived clinical precision.

Patient & Prescribing Data

Patients with dry eye disease or ocular surface inflammation undergoing refractive assessment

Addressing ocular surface inflammation prior to refraction leads to more stable tear film, reduced higher-order aberrations, improved measurement repeatability, and better patient satisfaction with prescriptions.

Clinical Best Practices

• Evaluate and manage ocular surface inflammation before performing refractive measurements.
• Use both objective and subjective refraction methods to identify variability caused by tear film instability.
• Delay finalizing prescriptions until tear film stability is achieved to reduce remakes and improve visual outcomes.
• Educate patients about the impact of tear film instability on vision fluctuations and the importance of ocular surface treatment.

References

• 1
• 2
• 3